腋窝淋巴结清扫与前哨淋巴结活检对乳腺癌患者上肢并发症的影响:系统综述与Meta分析
结果显示ALND后淋巴水肿和疼痛发生率均高于SLNB,且力量与活动度下降更常见,支持继续推进腋窝手术降阶梯。
要点
- ALND后淋巴水肿与疼痛发生率均高于SLNB,差异分别为13.7%和24.2%。
- ALND后力量下降与活动度受限的合并患病率均高于SLNB。
- 腋窝手术方式、较高体重指数和放疗是上肢并发症的预测因素。
核心结论
- ALND后淋巴水肿发生率高于既往估计,ALND患者淋巴水肿、疼痛、力量下降和活动度受限均多于SLNB,支持继续推进腋窝手术降阶梯。
研究设计与样本
- 遵循PRISMA指南,分析SLNB与ALND在<12个月、12至24个月及>24个月的上肢并发症患病率。
主要发现
- 所有纳入研究均报告ALND后淋巴水肿和疼痛发生率高于SLNB。
- SLNB与ALND间淋巴水肿患病率差异为13.7%(95%CI:10.5-16.8,P<0.005)。
- SLNB与ALND间疼痛患病率差异为24.2%(95%CI:12.1-36.3,P<0.005)。
- 力量下降合并患病率SLNB为15.2%、ALND为30.9%;活动度受限SLNB为17.1%、ALND为29.8%。
- 腋窝手术类型、较高体重指数和放疗是上肢并发症的部分预测因素。
关键数值与推荐
- 淋巴水肿患病率差异13.7%(95%CI:10.5-16.8,P<0.005),比较对象为SLNB与ALND。
- 疼痛患病率差异24.2%(95%CI:12.1-36.3,P<0.005),比较对象为SLNB与ALND。
- 力量下降合并患病率15.2% versus 30.9%,活动度受限17.1% versus 29.8%,比较对象为SLNB versus ALND。
临床怎么用
- 对乳腺癌患者制定腋窝手术方案时应权衡ALND与SLNB的上肢并发症负担,优先考虑降阶梯策略。
- 对接受ALND、体重指数较高或需放疗的患者,应加强淋巴水肿、疼痛、力量和活动度的监测与康复资源投入。
局限性
- 纳入研究为随机对照与观察性研究,异质性可能影响合并估计。
- 原文摘要未报告各时间段的单独患病率、研究间异质性指标及偏倚风险评估结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the impact of axillary lymph node dissection (ALND) and sentinel lymph node biopsy (SLNB) on upper limb (UL) morbidity in breast cancer patients. BACKGROUND: Axillary de-escalation is motivated by a desire to reduce harm of ALND. Understanding the impact of axillary surgery and disparities in operative procedures on postoperative arm morbidity would better direct resources to the point of need and cement the need for de-escalation strategies. METHODS: Embase, MEDLINE, CINAHL, and PsychINFO were searched from 1990 until March 2020. Included studies were randomized-controlled and observational studies focusing on UL morbidities, in breast surgery patients. The study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The prevalence of UL morbidity comparing SLNB and ALND at <12 months, 12 to 24 months, and beyond 24 months were analyzed. RESULTS: Sixty-seven studies were included. All studies reported a higher rate of lymphedema and pain after ALND compared with SLNB. The difference in lymphedema and pain prevalence between SLNB and ALND was 13.7% (95% confidence interval: 10.5-16.8, P <0.005) and 24.2% (95% confidence interval: 12.1-36.3, P <0.005), respectively. Pooled estimates for prevalence of reduced strength and range of motion after SLNB and ALND were 15.2% versus 30.9% and 17.1% versus 29.8%, respectively. Type of axillary surgery, greater body mass index, and radiotherapy were some of the predictors for UL morbidities. CONCLUSIONS: Prevalence of lymphedema after ALND was higher than previously estimated. ALND patients experienced greater rates of lymphedema, pain, reduced strength, and range of motion compared with SLNB. The findings support the continued drive to de-escalate axillary surgery.
引用
- Che Bakri NA, Kwasnicki RM, Khan N, et al. Impact of Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy on Upper Limb Morbidity in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Ann Surg. 2022. PMID: 35946806. doi:10.1097/SLA.0000000000005671
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。